Panel
Advancing the Frontier: Innovations in Health
- Technology, including AI, machine learning, and telemedicine, is projected to become a primary solution to healthcare deficits within the next 5 to 15 years, potentially triaging 80–90% of cases and making doctors 90% more productive without rendering them redundant.
- Global healthcare systems will likely leapfrog legacy physical infrastructure models, particularly in regions like India with no legacy constraints, by utilizing digital highways to reach populations faster than physical expansion allows.
- Chronic diseases, injuries, and road traffic fatalities are expected to outpace infectious diseases as leading causes of mortality, driven by aging populations and industrialization in Asia and poor countries, with road traffic fatalities projected to exceed combined deaths from malaria, HIV, and TB.
- Access to safe surgery and anesthesia remains limited for approximately 5 billion people (two-thirds of the global population), necessitating a shift from traditional approaches and supporting a World Health Assembly resolution with a 2030 roadmap.
- Cancer care faces a cost crisis in Asia where out-of-pocket expenditures are common, with treatment costs rising from a US$3,325 average family monthly payment in 2001 to US$13,250 in 2014, potentially reaching US$10,000–$12,000 per patient monthly in the future.
- Market dynamics will see a surge in molecular medicines and monoclonal antibodies, with projected mortality reductions despite rising costs, though 90% of cancers are attributed to "bad luck" rather than known genetic basis, with only 5–10% having a known genetic origin.
- Consumer expectations will shift toward immediate diagnostic information and monitoring, with patients increasingly demanding transparency on drug pricing and engaging via email, text, or WhatsApp, with over 40% potentially seeking cheaper generic alternatives.
- Future care models will transition from single transactions to life-cycle views supported by health repositories, DNA advancements for early detection, and behavior change incentives like micropayments and vitality programs.
- Regulatory environments will become more proactive, particularly in India, by establishing sandbox environments, one-window clearances, and interoperability protocols for electronic medical records to support startups that cannot wait for traditional approval timelines of five to ten years.
- Surgical technology will evolve through remote surgery performed by human surgeons soon, while full robot autonomy remains distant due to procedural nuances, with current robotic systems being more expensive and slower than traditional methods.
- Major technology corporations such as Google, Amazon, Samsung, and Facebook are expected to continue health initiatives, though their evolution will differ from other sectors due to necessary collaboration with regulators, providers, and peers.
- The global healthcare sector is positioned on the lower end of the S-curve, with immense potential for transformation through a mix of inexpensive prevention, education, primary care, and expensive specialist treatments.
- Societal demands for universal coverage will drive a revolution where technology serves as an enabler rather than a complete disruptor, balancing high-tech care with high-touch care to achieve better outcomes, improved quality, and lower costs.